Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1094 Articles

Jon C. Ogg | Jun 2, 2015 at 10:45 AM EDT

5 Stocks That Warren Buffett Should Sell — or Add to the Stake

It turns out that Buffett has five public stocks that used to be far larger stakes or which seem like…

Paul Ausick | May 22, 2015 at 4:01 PM EDT

The 4 Stocks That Sank the DJIA on Friday

thinkstockMay 22 2015: Markets opened mixed on Friday on a day that was tough on blue chips. The energy sector…

Jon C. Ogg | May 21, 2015 at 8:05 AM EDT

10 Companies to Own for the Next Decade

Back in November of 2010, 24/7 Wall St. first issued a list of stocks to own for the next decade.…

Chris Lange | May 20, 2015 at 9:55 AM EDT

Can Another 10 Blockbuster Drugs Really Come From Johnson & Johnson in 5 Years?

Johnson & Johnson has been working on its pharmaceuticals pipeline for a while, and plans on continuing to do so.

Paul Ausick | May 18, 2015 at 4:01 PM EDT

The 4 Stocks That Lifted the DJIA on Monday

thinkstockMay 18, 2015: Markets opened lower on Monday, but the financial and healthcare sectors led the indexes above the break-even…

Jon C. Ogg | May 14, 2015 at 1:00 PM EDT

Key Dalio and Bridgewater Position Changes: Alcoa, Apple, CenturyLink, Cisco, Gilead, Emerging Markets

It turns out that hedge fund Bridgewater Associates and founder Ray Dalio have made some changes since the end of…

Lee Jackson | May 14, 2015 at 10:25 AM EDT

UBS Adds Oil Field Services Giant to Dividend Ruler Stocks Portfolio

UBS has added one of the world's largest oilfield services companies to its Dividend Ruler portfolio. Top dividend stocks continue…

Mike Sauter | May 6, 2015 at 2:43 PM EDT

Companies With the Best (and Worst) Reputations

Goldman Sachs has the worst reputation of any major American company. Upstate New York-based grocery chain Wegmans is the most…

Chris Lange | May 5, 2015 at 10:50 AM EDT

Top Credit Suisse Major Pharma Stock Picks to Buy

Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.

Chris Lange | Apr 25, 2015 at 9:05 AM EDT

4 Dividends and Buybacks That Should Not Be Ignored

24/7 Wall St. has collected and compiled dividend and buyback announcements within the past week that should not be ignored…

Paul Ausick | Apr 24, 2015 at 4:01 PM EDT

The 4 Stocks That Dominated the DJIA on Friday

thinkstockApril 24, 2015: Markets opened higher on Friday but only the Nasdaq Composite was able to hold onto its opening…

Jon C. Ogg | Apr 23, 2015 at 11:55 AM EDT

After Dividend Hike at J&J, Investors Can Expect Many Years of More Hikes

Johnson & Johnson is at it again. The consumer products and health care products giant has raised its common stock…

Paul Ausick | Apr 16, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA Thursday

thinkstockApril 16, 2015: Markets opened lower on Thursday before climbing above the break-even line in the mid-afternoon. Crude oil futures…

Jon C. Ogg | Apr 15, 2015 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Chipotle, CSX, GoPro, Intel, Nike, Staples, Starbucks and More

Wednesday's top analyst upgrades, downgrades and initiations include Chipotle Mexican Grill, CSX, GoPro, Intel, Nike, Staples, Starbucks and Wells Fargo.

Jon C. Ogg | Apr 14, 2015 at 12:15 PM EDT

Over Half of DJIA Stocks Outyield 30-Year Treasury Bond

The 30-year Treasury Bond yields only about 2.5% and, amazingly, more than half of the 30 Dow Jones Industrial Average…

1 … 36 37 38 39 40 … 73

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

5 Stocks That Warren Buffett Should Sell — or Add to the Stake

The 4 Stocks That Sank the DJIA on Friday

10 Companies to Own for the Next Decade

Can Another 10 Blockbuster Drugs Really Come From Johnson & Johnson in 5 Years?

The 4 Stocks That Lifted the DJIA on Monday

Key Dalio and Bridgewater Position Changes: Alcoa, Apple, CenturyLink, Cisco, Gilead, Emerging Markets

UBS Adds Oil Field Services Giant to Dividend Ruler Stocks Portfolio

Companies With the Best (and Worst) Reputations

Top Credit Suisse Major Pharma Stock Picks to Buy

4 Dividends and Buybacks That Should Not Be Ignored

The 4 Stocks That Dominated the DJIA on Friday

After Dividend Hike at J&J, Investors Can Expect Many Years of More Hikes

The 4 Stocks That Weighed on the DJIA Thursday

Top Analyst Upgrades and Downgrades: Chipotle, CSX, GoPro, Intel, Nike, Staples, Starbucks and More

Over Half of DJIA Stocks Outyield 30-Year Treasury Bond

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

5 Stocks That Warren Buffett Should Sell — or Add to the Stake

The 4 Stocks That Sank the DJIA on Friday

10 Companies to Own for the Next Decade

Can Another 10 Blockbuster Drugs Really Come From Johnson & Johnson in 5 Years?

The 4 Stocks That Lifted the DJIA on Monday

Key Dalio and Bridgewater Position Changes: Alcoa, Apple, CenturyLink, Cisco, Gilead, Emerging Markets

UBS Adds Oil Field Services Giant to Dividend Ruler Stocks Portfolio

Companies With the Best (and Worst) Reputations

Top Credit Suisse Major Pharma Stock Picks to Buy

4 Dividends and Buybacks That Should Not Be Ignored

The 4 Stocks That Dominated the DJIA on Friday

After Dividend Hike at J&J, Investors Can Expect Many Years of More Hikes

The 4 Stocks That Weighed on the DJIA Thursday

Top Analyst Upgrades and Downgrades: Chipotle, CSX, GoPro, Intel, Nike, Staples, Starbucks and More

Over Half of DJIA Stocks Outyield 30-Year Treasury Bond

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts